Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

 
Abstract

Volume 17, Issue 6 (November 2015) 17, 863–863; 10.4103/1008-682X.156860

The International Prostate Forum introduction and history

John W Davis, Tsuneharu Miki, Atif Akdas, Hiroki Watanabe, Ziya Kirkali, Run Wang, R Joseph Babaian

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan
Department of Urology, School of Medicine, Marmara University, Istanbul, Turkey
Watanabe Memorial Choumei Research Laboratory, Shiga, Japan
Dokuz Eylül University School of Medicine, Department of Urology, Izmir, Turkey
Division of Urology, University of Texas Medical School at Houston, Department of Urology; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Department of Urology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA

Correspondence: Dr. JW Davis

26 June 2015

Abstract

The International Prostate Forum (IPF) originally started with three urology departments in Japan, Turkey, and the United States. The forum emphasized discussions and presentations of new knowledge in all areas of prostate diseases with an early emphasis on ultrasound and diagnostics. The meeting has generally run every 2 years and rotated through the three sites with new leaders joining the effort. Over the years, the meeting has enjoyed a diverse locale and points of emphasis. The latter agendas now cover all aspects of the benign prostate disease, prostate cancer screening, prostate cancer diagnosis and staging, and therapies. [Table 1] summarizes the dates of the meetings, locations, and chairman.

Full Text | PDF | 中文摘要 |

 
Browse:  2022
 
Copyright 1999-2017  Shanghai Materia Medica, Shanghai Jiao Tong University.  All rights reserved